4/A
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-002418
Director sold 15,000 shares at an average $29.29 ($439,351)
- Director acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
DOBMEIER ERIC · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-12-26 | Exercise or conversion : show line 1 in the form | +15,000 | $6.32 | $94,800 | 15,000 | D |
| 2019-12-26 | Sale : show line 2 in the form | −14,998 | $29.29 | $439,291 | 2 | D |
| 2019-12-26 | Sale : show line 3 in the form | −2 | $29.91 | $60 | 0 | D |
| Open-market sales · 15,000 sh · avg $29.29 · $439,351 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-12-26 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −15,000 | 85,000 | D |
Loading xslF345X03/doc4a.xml…